Mode
Text Size
Log in / Sign up

Prevalence of neurogenic bladder in patients with multiple sclerosis and associated urinary symptomsNearly half of people with MS have bladder problems

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Recognize the high prevalence of neurogenic bladder in multiple sclerosis to inform standardized screening practices.

The study examined the pooled prevalence of neurogenic bladder and its associated subtypes, including storage symptoms, voiding symptoms, and mixed symptoms, in a large cohort of people with multiple sclerosis. The analysis identified that a substantial proportion of these patients experience some form of neurogenic bladder, with varying rates observed for specific symptom types.

The authors noted significant heterogeneity across the included studies. This variability was primarily attributed to inconsistent diagnostic definitions, differing assessment instruments, and diverse study designs. These inconsistencies highlight the challenges in establishing a uniform prevalence rate across different clinical settings.

Clinically, the results suggest that neurogenic bladder is a common complication for those living with multiple sclerosis. While meta-regression did not find significant associations between bladder prevalence and factors like age or disease duration, the findings underscore the importance of consistent monitoring. Standardized screening and assessment strategies are recommended to improve early identification and optimize care pathways for these patients.

A new analysis of existing research finds that bladder problems are very common in people with multiple sclerosis (MS). The analysis, which pooled data from many studies, estimates that nearly half of people with MS, about 48.8%, have a condition called neurogenic bladder, where the bladder doesn't work properly due to nerve damage.

The analysis included data from 39,304 people with MS. It looked at different types of bladder symptoms. Storage symptoms, like feeling the need to urinate often or urgently, were the most common, affecting about 39.1% of people. Mixed symptoms, which include both storage and voiding problems, were also common, affecting about 40.9%. Voiding symptoms, such as trouble starting to urinate or a weak stream, affected about 21.4%.

It's important to note that the studies varied widely, with the prevalence of bladder problems ranging from 6% to 94% across different studies. This variation is likely due to differences in how bladder problems were defined and measured. The analysis did not find that age, disability level, or disease duration were linked to the likelihood of having bladder problems.

The main takeaway is that bladder issues are a common and significant problem for people with MS. The authors suggest that standardized screening and assessment could help identify these issues earlier and improve care. If you have MS and are experiencing bladder symptoms, it's important to talk to your doctor about them.

What this means for you:
Bladder problems affect nearly half of people with MS, so it's important to discuss any symptoms with your doctor.

Common questions

How common is neurogenic bladder in people with MS?

According to this analysis, about 48.8% of people with MS have neurogenic bladder. This means nearly half of people with MS may experience bladder problems due to nerve damage.

What are the most common bladder symptoms in MS?

The analysis found that storage symptoms, like frequent or urgent urination, affect about 39.1% of people with MS. Mixed symptoms, which include both storage and voiding problems, affect about 40.9%. Voiding symptoms, such as trouble starting to urinate, affect about 21.4%.

Why do bladder problems vary so much among people with MS?

The prevalence of bladder problems ranged from 6% to 94% across different studies. This wide range is likely due to differences in how bladder problems are defined and measured in research. The analysis noted high heterogeneity, meaning the studies were very different from each other.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedAug 2026
View Original Abstract ↓
BACKGROUND: Neurogenic bladder (NGB) is one of the most common and debilitating manifestations of multiple sclerosis (MS), substantially impairing quality of life and increasing the risk of secondary complications. OBJECTIVE: To determine the pooled prevalence of NGB and its subtypes in people with MS (PwMS). METHODS: A systematic review and meta-analysis was conducted in accordance with PRISMA and MOOSE guidelines and was prospectively registered in PROSPERO. The MEDLINE, Embase, Scopus, and Google Scholar databases were searched. Risk of bias was assessed using the ROBINS-E scale. Pooled prevalence estimates were calculated using a random-intercept generalized linear mixed model (GLMM) with logit transformation and Hartung-Knapp adjustment. Meta-regression and subgroup analyses were performed to explore heterogeneity, and sensitivity analyses included leave-one-out analysis and prediction intervals. RESULTS: Twenty-two studies comprising 39,304 PwMS were included. The pooled prevalence of NGB was 48.8% (95% CI: 34.1-63.7%). Subtype analyses showed pooled prevalences of 39.1% for storage symptoms, 21.4% for voiding symptoms, and 40.9% for mixed symptoms. Meta-regression did not identify significant associations between NGB prevalence and age, EDSS, or disease duration. Sensitivity and subgroup analyses indicated that heterogeneity (I² > 97%) was primarily attributable to differences in diagnostic definitions, assessment instruments, and study design rather than demographic or clinical characteristics. CONCLUSIONS: NGB affects approximately one in two PwMS with the prevalence ranging from 6 to 94%. Standardized screening and assessment strategies are warranted to improve early identification and optimize care pathways.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.